Skip to main content

Peer Review reports

From: Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case report

Original Submission
6 Jun 2018 Submitted Original manuscript
29 Jun 2018 Reviewed Reviewer Report - Maria Jové
1 Sep 2018 Reviewed Reviewer Report - Carles Escriu
26 Oct 2018 Author responded Author comments - Johan Pluvy
Resubmission - Version 2
26 Oct 2018 Submitted Manuscript version 2
3 Nov 2018 Reviewed Reviewer Report - Maria Jové
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
28 Dec 2018 Editorially accepted
11 Jan 2019 Article published 10.1186/s12890-018-0775-5

You can find further information about peer review here.

Back to article page